Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Segment Reporting Information [Line Items]
Total Consolidated Revenue	$ 365,623	$ 230,213	$ 1,025,891	$ 683,435
Total consolidated operating income excluding special items	76,523	40,824	183,194	124,436
Restructuring expense	(10,518)	(1,217)	(16,999)	(5,299)
Business acquisition and integration expense	(5,924)	(3,646)	(41,537)	(28,161)
Total consolidated operating (loss) income	33,264	35,961	35,935	90,976
Net other expense	(35,540)	(7,166)	(107,123)	(10,848)
Total consolidated (loss) income from continuing operations before income taxes	(2,276)	28,795	(71,188)	80,128
Total Consolidated Assets	3,518,460	3,061,785	3,518,460	3,061,785	$ 3,084,843
Total Consolidated capital expenditures	7,477	8,887	22,249	28,591
Total consolidated depreciation expense	11,341	8,603	33,471	25,325
Total consolidated intangible asset amortization expense	26,817	0	73,967	0
Discontinued Operations, Held-for-sale [Member]
Segment Reporting Information [Line Items]
Total Consolidated Assets	1,525	592,986	1,525	592,986
Chamberlain University Segment [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	142,550	146,313	417,310	422,054
Total consolidated operating income excluding special items	38,910	36,107	85,556	98,758
Total Consolidated Assets	220,915	205,625	220,915	205,625
Total Consolidated capital expenditures	3,255	6,876	9,869	19,470
Total consolidated depreciation expense	4,738	4,091	14,048	11,998
Walden University
Segment Reporting Information [Line Items]
Total Consolidated Revenue	139,081	0	348,325	0
Total consolidated operating income excluding special items	26,188	0	69,601	0
Total Consolidated Assets	1,509,866	0	1,509,866	0
Total Consolidated capital expenditures	1,629	0	4,561	0
Total consolidated depreciation expense	2,573	0	6,801	0
Total consolidated intangible asset amortization expense	26,817	0	73,967	0
Medical and Veterinary [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	83,992	83,900	260,256	261,381
Total consolidated operating income excluding special items	19,482	14,977	54,853	56,626
Restructuring expense	(4,569)		(4,757)
Total Consolidated Assets	731,049	733,747	731,049	733,747
Total Consolidated capital expenditures	891	526	2,650	2,821
Total consolidated depreciation expense	3,397	3,646	10,497	10,802
Home Office and Other
Segment Reporting Information [Line Items]
Total consolidated operating income excluding special items	(8,057)	(10,260)	(26,816)	(30,948)
Restructuring expense	(1,793)	(1,217)	(5,960)	(5,299)
Total Consolidated Assets	1,055,105	1,529,427	1,055,105	1,529,427
Total Consolidated capital expenditures	1,702	1,485	5,169	6,300
Total consolidated depreciation expense	633	866	2,125	2,525
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Deferred revenue adjustment	0	0	(8,561)	0
CEO transition costs	0	0	(6,195)	0
Restructuring expense	(10,518)	(1,217)	(16,999)	(5,299)
Business acquisition and integration expense	(5,924)	(3,646)	(41,537)	(28,161)
Total consolidated intangible asset amortization expense	$ 26,817	$ 0	$ 73,967	$ 0